PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10199742-2	1999	METHODS: Because administration of the principal ligand of CD44, hyaluronate (HA), in soluble form, can inhibit CD44-HA interaction, we tested the effects of HA in vivo in an established model of chronic allograft rejection.	ha	78-80	CD44 molecule (Indian blood group)	Homo sapiens	59-63	
10199742-2	1999	METHODS: Because administration of the principal ligand of CD44, hyaluronate (HA), in soluble form, can inhibit CD44-HA interaction, we tested the effects of HA in vivo in an established model of chronic allograft rejection.	ha	78-80	CD44 molecule (Indian blood group)	Homo sapiens	112-116